• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

HPV vaccine associated with minimal adverse effects

bys25qthea
October 3, 2012
in Infectious Disease, Oncology, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: CC/VNU CNS

Key study points:

1. The quadrivalent HPV vaccine is associated with an increased risk of same-day syncope and injection site reactions in the post-vaccination period compared to a control period more remote in time from the vaccination.

2. No new major safety risks were identified for the quadrivalent HPV vaccine.

Primer: Approximately 70% of cervical, vaginal and anal cancers are caused by HPV (Human Papillomavirus) genotypes 16 and 18. HPV genotypes 6 and 11 are major causes of genital warts. The quadrivalent HPV vaccine (brand-name: Gardasil) targets HPV genotypes 6, 11, 16 and 18. The vaccine was approved by the FDA in June 2006 for females 9 to 26 years of age. The vaccine is supposed to be administered in three doses: time 0, 2 months and 6 months.

The FUTURE I and II phase 3 trials demonstrated that the vaccine was effective and that it was most effective in HPV-naïve females. Guidelines recommend routine vaccination of girls as early as 9 years of age. Some groups also recommend catch-up vaccinations for women aged 13 to 26 years, but this has been challenged on grounds of cost-effectiveness.

Post-licensure surveillance done by the CDC has not found a higher rate of adverse events compared to other vaccines, except for disproportional reporting of syncope and venous thromboembolism (VTE). Most of the patients with VTE had known risk factors such as smoking, OCP use or clotting disorders.  The most commonly reported adverse events are syncope, followed by pain and redness at the injection site.

RELATED REPORTS

Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy

Operating the day after performing surgery the previous night not associated with adverse patient outcomes

Gratitude-focused writing may improve mental wellness during periods of chronic stress

Background reading:

1. Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24, Supplement 3(0):S1–S10.
2. The FUTURE II Study Group. Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions. New England Journal of Medicine. 2007;356(19):1915–1927.
3. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases. New England Journal of Medicine. 2007;356(19):1928–1943.
4. Slade BA, Leidel L, Vellozzi C, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA. 2009;302(7):750–757.
 

This [retrospective, observational cohort] study was conducted within the Kaiser Permanente systems of Northern and Southern California. The cohort consisted of 189,629 females between 9 and 26 years of age who had received at least one dose of the quadrivalent vaccine. A subset of 44,001 individuals in the cohort received all 3 doses of the vaccine. 

Safety of the vaccine was assessed by comparing the odds of post-vaccination emergency department visits and hospitalizations within a short period after the vaccination to the odds of ED visits and hospitalizations in a period more remote from the vaccination. Adverse events were classified using ICD-9 codes.

An association was found between the vaccine and syncope on the day of the injection (OR 6.0; 95% CI, 3.9 – 9.2). There was also an association with skin infections in the 2 weeks after vaccination (OR 1.8; 95% CI, 1.3 – 2.4), though medical record review suggested that these might have been local injection site reactions. No association was found between HPV vaccination and VTE.

In sum: This study, undertaken as a post-licensure commitment to the FDA and the European Medicines Agency, finds no new major safety concerns related to the quadrivalent HPV vaccine.  

One of this study’s strengths is its large cohort. However, the study was not designed to detect adverse events beyond 60 to 180 days of vaccination. The study also would not have detected adverse events that were not severe enough to warrant an ED visit or hospitalization. Finally, medical record validation was only performed for select diagnoses.

Click to read the study in the Archives of Pediatrics & Adolescent Medicine

By TJ and MP

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCALIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

High risk of vitamin D deficiency in breast-fed infants receiving vitamin D supplementation

Next Post

Obesity phenotypes in midlife linked to cognitive decline in old age

RelatedReports

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial
Chronic Disease

Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy

May 24, 2022
Quick Take: Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery
Public Health

Operating the day after performing surgery the previous night not associated with adverse patient outcomes

May 24, 2022
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse
Psychiatry

Gratitude-focused writing may improve mental wellness during periods of chronic stress

May 24, 2022
Patient Basics: Lung Cancer Overview
Oncology

Adebrelimab plus chemotherapy improves overall survival in extensive-stage small-cell lung cancer

May 23, 2022
Next Post

Obesity phenotypes in midlife linked to cognitive decline in old age

High upstage rate among nonmalignant papillary breast lesions diagnosed by image-guided core needle biopsy

Vitamin D supplementation does not decrease incidence of viral upper respiratory tract infections

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy
  • Operating the day after performing surgery the previous night not associated with adverse patient outcomes
  • Gratitude-focused writing may improve mental wellness during periods of chronic stress
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.